5vj3
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==HIV Protease (PR) in open form with Mg2+ in active site and HIVE-9 in eye site== | ==HIV Protease (PR) in open form with Mg2+ in active site and HIVE-9 in eye site== | ||
| - | <StructureSection load='5vj3' size='340' side='right' caption='[[5vj3]], [[Resolution|resolution]] 2.00Å' scene=''> | + | <StructureSection load='5vj3' size='340' side='right'caption='[[5vj3]], [[Resolution|resolution]] 2.00Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5vj3]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5VJ3 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5VJ3 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5vj3]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/9hiv1 9hiv1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5VJ3 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5VJ3 FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=HV9:4-methyl-N-({1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl}carbamoyl)benzene-1-sulfonamide'>HV9</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=HV9:4-methyl-N-({1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl}carbamoyl)benzene-1-sulfonamide'>HV9</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5to9|5to9]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5to9|5to9]]</td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">pol ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=11676 9HIV1])</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] </span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5vj3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5vj3 OCA], [http://pdbe.org/5vj3 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5vj3 RCSB], [http://www.ebi.ac.uk/pdbsum/5vj3 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5vj3 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5vj3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5vj3 OCA], [http://pdbe.org/5vj3 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5vj3 RCSB], [http://www.ebi.ac.uk/pdbsum/5vj3 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5vj3 ProSAT]</span></td></tr> | ||
| Line 12: | Line 13: | ||
</StructureSection> | </StructureSection> | ||
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Stout, C D]] | [[Category: Stout, C D]] | ||
[[Category: Tiefenbrunn, T]] | [[Category: Tiefenbrunn, T]] | ||
Revision as of 09:35, 1 January 2020
HIV Protease (PR) in open form with Mg2+ in active site and HIVE-9 in eye site
| |||||||||||
